Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab

• Status: Unknown status
• Trial end date: 2012-07-01
• Target enrollment: 0
• Participant gender: All

Summary

Does treatment with bevacizumab (Avastin) in combination with prior or current radiotherapy lead to optic neuropathy?

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: West Penn Allegheny Health System
• Treatments: Bevacizumab

Criteria

Inclusion Criteria:

• Diagnosed w Glioblastoma grade IV, and scheduled to begin chemo radiotherapy with Avastin

Exclusion Criteria:

• No diagnosis of GBM, not scheduled to begin treatment with avastin in combination with radiotherapy.